Harte Hanks, Inc. (NASDAQ:HHS) Q1 2024 Earnings Call Transcript
Operator: Greetings. Welcome to the Harte Hanks First Quarter 2024 Earnings Conference Call. At this time, all participants are in a listen-only mode.
Harte Hanks Inc (HHS)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Westerly Capital Management Jim Tarantino And Chris Galvin | 699,000 | $5,228,520 | +1% | 1.98% |
| 2. | GLG Partners Noam Gottesman | 65,537 | $490,217 | -12% | 0% |
| 3. | Two Sigma Advisors John Overdeck And David Siegel | 19,800 | $148,104 | -26% | 0% |
| 4. | Citadel Investment Group Ken Griffin | 11,218 | $83,911 | +2% | 0% |
| 5. | Renaissance Technologies Jim Simons | 31,300 | $234,000 | +4% | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.19 | 25,000 | Director | 241,283 | 0024-05-15 | Filing | |
| $7.01 | 127 | Officer | 22,331 | 2024-05-13 | Filing | |
| $6.99 | 1 | Officer | 22,204 | 2024-05-13 | Filing | |
| $7.00 | 300 | Officer | 22,203 | 2024-05-13 | Filing | |
| $7.10 | 6,000 | Officer | 21,903 | 2024-05-13 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $16.31 | 20,000 | Director | 160,000 | 2022-08-17 | Filing | |
| $15.17 | 333,502 | Director | 180,000 | 2022-08-16 | Filing | |
| $15.17 | 50,000 | Director | 0 | 2022-08-16 | Filing | |
| $15.17 | 2,847 | Director | 46,283 | 2022-08-16 | Filing | |
| $15.12 | 77,651 | Director | 49,130 | 2022-08-15 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 660,845 | $4,487,138 | 0.01% | |
| 2. | 304,210 | $2,065,586 | 0% | |
| 3. | 126,872 | $861,461 | 0% | |
| 4. | 91,500 | $621,285 | 0.05% | |
| 5. | 67,444 | $458,030 | 0% |
News See All
Harte Hanks, Inc. (NASDAQ:HHS) Q3 2023 Earnings Call Transcript
Operator: Greetings, and welcome to the Harte Hanks Third Quarter 2023 Earnings Call. [Operator Instructions] Please note, this conference is being recorded.
Harte Hanks, Inc. (NASDAQ:HHS) Q2 2023 Earnings Call Transcript
Operator: Greetings and welcome to the Harte Hanks Second Quarter 2023 Earnings Call. [Operator Instructions] Please note, this conference is being recorded.
Harte Hanks, Inc. (NASDAQ:HHS) Q1 2023 Earnings Call Transcript
Operator: Greetings and welcome to the Harte Hanks' First Quarter 2023 Earnings Conference Call. Please note this conference is being recorded.
Harte Hanks, Inc. (NASDAQ:HHS) Q4 2022 Earnings Call Transcript
Operator: Greetings and welcome to the Harte Hanks' Fourth Quarter and Full Year 2022 Earnings Conference Call. Please note this conference is being recorded.
Hedge Fund and Insider Trading News: Ray Dalio, Ken Griffin, Cinctive Capital Management, Godaddy Inc (GDDY), Canaccord Genuity Group Inc (CCORF), and More
Legendary hedge fund investor Ray Dalio is renowned figure in the world of finance, but is equally famous for his views on life, investing, and much more.
13D Filing: Fondren Management and Harte Hanks Inc (NYSE:HHS)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240...
Is Harte Hanks Inc (HHS) A Good Stock To Buy?
Hedge funds run by legendary names like Nelson Peltz and David Tepper make billions of dollars a year for themselves and their super-rich accredited investors (you’ve got to have a minimum of $1 million...
Investors Are Gaining Confidence In Harte-Hanks, Inc. (HHS)
How do you pick the next stock to invest in? One way would be to spend hours of research browsing through thousands of publicly-traded companies.
Pzena Investment Management Trims Exposure to Harte-Hanks, Inc. (HHS)
A new filing with the Securities and Exchange Commission, revealed that Richard S. Pzena's Pzena Investment Management has reduced its position in Harte-Hanks, Inc. (NYSE:HHS).
Billionaire Hedge Funds
